Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
Aug 18, 2025
29:55
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.
Annals On Call Podcast